Liver cancer drug shows promise in Late-Stage patients
Disease control
Completed
This study tested the drug sorafenib in 50 adults with advanced liver cancer that had worsened after at least one prior treatment. Participants took sorafenib daily to see if it could slow tumor growth and improve survival. The trial measured how long patients lived without their…
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC